CZ20012876A3 - SP-C analogy - Google Patents

SP-C analogy

Info

Publication number
CZ20012876A3
CZ20012876A3 CZ20012876A CZ20012876A CZ20012876A3 CZ 20012876 A3 CZ20012876 A3 CZ 20012876A3 CZ 20012876 A CZ20012876 A CZ 20012876A CZ 20012876 A CZ20012876 A CZ 20012876A CZ 20012876 A3 CZ20012876 A3 CZ 20012876A3
Authority
CZ
Czechia
Prior art keywords
analogs
Prior art date
Application number
CZ20012876A
Other languages
English (en)
Other versions
CZ301108B6 (cs
Inventor
Tore Curstedt
Jan Johansson
Hans Jornvall
Bengt Robertson
Paolo Ventura
Original Assignee
Chiesi Farmaceutici S. P. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S. P. A. filed Critical Chiesi Farmaceutici S. P. A.
Publication of CZ20012876A3 publication Critical patent/CZ20012876A3/cs
Publication of CZ301108B6 publication Critical patent/CZ301108B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CZ20012876A 1999-02-12 2000-02-09 SP-C analogy CZ301108B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI000275A IT1308180B1 (it) 1999-02-12 1999-02-12 Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Publications (2)

Publication Number Publication Date
CZ20012876A3 true CZ20012876A3 (cs) 2002-06-12
CZ301108B6 CZ301108B6 (cs) 2009-11-11

Family

ID=11381859

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20012876A CZ301108B6 (cs) 1999-02-12 2000-02-09 SP-C analogy

Country Status (32)

Country Link
US (1) US7053044B1 (cs)
EP (1) EP1151008B1 (cs)
JP (1) JP4754073B2 (cs)
KR (1) KR100645145B1 (cs)
CN (1) CN1221570C (cs)
AR (1) AR022578A1 (cs)
AT (1) ATE280181T1 (cs)
AU (1) AU758735B2 (cs)
BG (1) BG65196B1 (cs)
BR (1) BR0009964A (cs)
CA (1) CA2362507C (cs)
CO (1) CO5241361A1 (cs)
CZ (1) CZ301108B6 (cs)
DE (1) DE60015082T2 (cs)
EA (1) EA004058B1 (cs)
EE (1) EE04879B1 (cs)
ES (1) ES2228473T3 (cs)
GE (1) GEP20032976B (cs)
HU (1) HU228997B1 (cs)
IL (1) IL144842A0 (cs)
IT (1) IT1308180B1 (cs)
MA (1) MA25381A1 (cs)
NO (1) NO20013888D0 (cs)
NZ (1) NZ513451A (cs)
PL (1) PL201084B1 (cs)
PT (1) PT1151008E (cs)
SK (1) SK286428B6 (cs)
TR (1) TR200102308T2 (cs)
UA (1) UA72751C2 (cs)
WO (1) WO2000047623A1 (cs)
YU (1) YU57701A (cs)
ZA (1) ZA200106530B (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
JP2003522138A (ja) * 2000-02-11 2003-07-22 アルタナ ファルマ アクチエンゲゼルシャフト 慢性肺疾患の予防および治療のための肺表面活性剤の新規使用
DK1340506T3 (da) * 2002-03-01 2007-05-07 Chiesi Farma Spa Sammensætninger omfattende pulmonære tensider og et polymyxin med forbedrede overfladeegenskaber
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
CN100401896C (zh) * 2002-12-09 2008-07-16 儿童医院医疗中心 诊断和治疗间质性肺病的方法
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
AU2004268386A1 (en) * 2003-08-28 2005-03-10 Nycomed Gmbh Use of surfactant preparations for the treatment of surgical adhesions
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
WO2008011559A2 (en) 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
CN103169947B (zh) * 2006-10-13 2014-10-29 奇斯药制品公司 具有改进性质的重组表面活性剂
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8048043B2 (en) 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
WO2010075416A1 (en) 2008-12-23 2010-07-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
BR112012004651B1 (pt) 2009-09-08 2022-02-08 Chiesi Farmaceutici S.P.A. Surfactante pulmonar exógeno, uso de uma combinação terapêutica, medicamento e kit
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
KR102051677B1 (ko) * 2012-04-23 2019-12-03 키에시 파르마슈티시 엣스. 피. 에이. 분무화에 의한 폐계면활성제의 투여를 위한 방법 및 시스템
EP2922868B1 (en) * 2012-11-21 2017-09-27 Chiesi Farmaceutici S.p.A. Reconstituted pulmonary surfactants
US20180110948A1 (en) 2015-04-22 2018-04-26 Chiesi Farmaceutici S.P.A Method and system for effective breath-synchronized delivery of medicament to the lungs
EP3106090A1 (en) 2015-06-15 2016-12-21 CHIESI FARMACEUTICI S.p.A. System for effective breath-synchronized delivery of medicament to the lungs
WO2016173634A1 (en) 2015-04-28 2016-11-03 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
CN107979996A (zh) * 2015-04-30 2018-05-01 不莱梅大学 新的皮肤医疗和美容护理产品
MA45772A (fr) 2016-07-28 2021-04-28 Chiesi Farm Spa Procédé et système d'administration d'un médicament sous forme d'aérosol
AU2017349790A1 (en) 2016-10-26 2019-05-02 Chiesi Farmaceutici S.P.A. Device for facilitating the administration of a medicament to the lung by a catheter
CN110099695B (zh) 2016-12-22 2022-01-25 奇斯药制品公司 用于治疗进展性bpd的包含肺表面活性物质和类固醇的治疗组合
TW201927286A (zh) 2017-12-15 2019-07-16 義大利商凱西製藥公司 用於噴霧投藥之包含肺表面張力素的藥學調配物
WO2019115771A1 (en) 2017-12-15 2019-06-20 Pari Pharma Gmbh Nebuliser system, holding system, combination comprising nebuliser system and holding system, and aerosol administration method
JP7378425B2 (ja) 2018-04-23 2023-11-13 シエシー ファルマセウティチィ ソシエタ ペル アチオニ 肺サーファクタントおよびｂｐｄの予防のためのステロイドを含む治療的組合せ
EP3666315A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3666316A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3843105A1 (en) 2019-12-23 2021-06-30 PARI Pharma GmbH Control device for aerosol nebulizer system
WO2021151853A1 (en) 2020-01-28 2021-08-05 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
CN114159546B (zh) * 2021-12-20 2024-06-04 北京双鹤润创科技有限公司 新一代合成肺表面活性物质制剂及其临床应用
EP4411745A1 (en) 2023-02-01 2024-08-07 Pari Medical Holding GmbH Medical evaluation method, aerosol nebulizer and medical evaluation system
EP4464354A1 (en) 2023-05-15 2024-11-20 Pari Medical Holding GmbH Method of operating an inhalation device, inhalation device and inhalation device system for providing inhalation process/breath guiding
EP4464236A1 (en) 2023-05-15 2024-11-20 Pari Medical Holding GmbH Method of operating an inhalation device, inhalation device and inhalation device system for providing inhalation process feedback

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
SE8803713D0 (sv) 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
ES2189825T3 (es) * 1993-12-08 2003-07-16 Mitsubishi Pharma Corp Nuevo peptido sintetico, tensioactivo pulmonar que lo contiene y remedio para el sindrome de malestar respiratorio.
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Also Published As

Publication number Publication date
YU57701A (sh) 2003-07-07
DE60015082D1 (de) 2004-11-25
NO20013888L (no) 2001-08-09
PT1151008E (pt) 2005-01-31
EA200100749A1 (ru) 2002-02-28
AU758735B2 (en) 2003-03-27
EA004058B1 (ru) 2003-12-25
AU3279300A (en) 2000-08-29
CO5241361A1 (es) 2003-01-31
EE200100413A (et) 2002-12-16
UA72751C2 (en) 2005-04-15
CN1340060A (zh) 2002-03-13
HUP0200141A2 (en) 2002-06-29
GEP20032976B (en) 2003-05-27
PL349785A1 (en) 2002-09-09
HK1042500A1 (en) 2002-08-16
US7053044B1 (en) 2006-05-30
NO20013888D0 (no) 2001-08-09
DE60015082T2 (de) 2006-02-09
JP2002541062A (ja) 2002-12-03
BG65196B1 (bg) 2007-06-29
AR022578A1 (es) 2002-09-04
ITMI990275A1 (it) 2000-08-12
EP1151008B1 (en) 2004-10-20
PL201084B1 (pl) 2009-03-31
CN1221570C (zh) 2005-10-05
CZ301108B6 (cs) 2009-11-11
WO2000047623A1 (en) 2000-08-17
ZA200106530B (en) 2002-10-14
IT1308180B1 (it) 2001-12-07
HU228997B1 (en) 2013-07-29
TR200102308T2 (tr) 2002-04-22
NZ513451A (en) 2003-05-30
BG105764A (en) 2002-03-29
HUP0200141A3 (en) 2002-09-30
CA2362507C (en) 2012-01-03
ES2228473T3 (es) 2005-04-16
ATE280181T1 (de) 2004-11-15
BR0009964A (pt) 2002-04-09
MA25381A1 (fr) 2002-04-01
SK11442001A3 (sk) 2001-12-03
KR20010101904A (ko) 2001-11-15
SK286428B6 (sk) 2008-09-05
EP1151008A1 (en) 2001-11-07
EE04879B1 (et) 2007-08-15
KR100645145B1 (ko) 2006-11-10
IL144842A0 (en) 2002-06-30
CA2362507A1 (en) 2000-08-17
JP4754073B2 (ja) 2011-08-24

Similar Documents

Publication Publication Date Title
HUP0202812A3 (en) Novel bicyclonucleoside analogues
HUP0202017A3 (en) Novel compounds
GB9926302D0 (en) Novel compounds
EP1140083A4 (en) NEW CONNECTIONS
GB9902084D0 (en) Novel compounds
GB9928673D0 (en) Novel compounds
EG24063A (en) Novel compounds
AU6550800A (en) Hepoxilin analogs
GB9923157D0 (en) Novel compounds
GB9902168D0 (en) Novel compounds
GB9925467D0 (en) Novel compounds
GB9917255D0 (en) Novel compounds
GB9922844D0 (en) Novel compounds
GB9902086D0 (en) Novel compounds
GB9913780D0 (en) Novel compounds
GB9913830D0 (en) Novel compounds
GB9900952D0 (en) Novel compounds
GB9908023D0 (en) Novel compounds
GB9926532D0 (en) Novel compounds
GB9922858D0 (en) Novel compounds
GB9901078D0 (en) Novel compounds
GB9923536D0 (en) Novel compounds
GB9927221D0 (en) Novel compounds
GB9921693D0 (en) Novel compounds
GB9900162D0 (en) Novel compounds

Legal Events

Date Code Title Description
MK4A Patent expired

Effective date: 20200209